Kiyotsugu Iede
3PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Sep 05, 2025
Poor Performance Status, Diabetes Mellitus, and Statin Use Are Risk Factors for Decreased Skeletal Muscle Mass During Nab-Paclitaxel Plus Gemcitabine Therapy in Patients With Advanced Pancreatic Cancer.Kiyotsugu Iede, Terumasa Yamada, Hirotoshi Takayama
|May 21, 2025
Prognostic Significance of ABO Blood Type in Patients with Advanced Pancreatic Cancer Treated with Nab-Paclitaxel Plus Gemcitabine.Kiyotsugu Iede, Terumasa Yamada, Hirotoshi Takayama
|Jul 22, 2022
Do antihypertensive drugs really have antitumor effects? Baseline differences in hypertensive and non-hypertensive patients with advanced pancreatic cancer.Kiyotsugu Iede, Terumasa Yamada, Masami Ueda
Pageof 1
